1CHEUNG N,MITCHELL P,WONG T Y.Diabetic retinopathy[J].Lancet,2010,376(9735):124-136.
2KOLLIAS A N,ULBIG M W.Diabetic retinopathy:early diagnosis and effective treatment[J].Dtsch Arztebl Int,2010,107(5):75-84.
3Early Treatment Diabetic Retinopathy Study Research Group.Fluoreocein angiographic risk factors for progression of diabetic retinopathy[J].Ophthalmology,1991,98(5):834-840.
4ADAMIS A P,MILLER J W,BERNAL M T,et al.Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy[J].Am J Ophthalmol,1994,118(4):445-450.
5HOFMAN P,VAN BLIJSWIJK B C,GAILLARD P J,et al.Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina:new insights into the pathogenesis of capillary nonperfusion[J].Arch Ophthalmol,2001,119(6):861-866.
6KUROKI M,KAWAKAMI M.Diabetic retinopathy-the mechinisms of the ocular nevascularization and the development of antiangiogemic drugs[J].Nippon Rinsho,1999,57(3):584-589.
7KOHNER E M,PATEL V,RASSAM S M.Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy[J].Diabetes,1995,44(6):603-607.
8CHAKRABARTI S,GAN X T,MERRY A,et al.Augmented retinal endothelin-1,endothelin-3,endothelinA and endothelinB gene expression in chronic diabetes[J].Curr Eye Res,1998,17(3):301-307.
9CHAKRABARTI S,SIMA A A.Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats[J].Diabetes Res Clin Pract,1997,37(2):109-120.
